ClinicalTrialsFinder

DLL3-expressing Tumors Clinical Trials in San Francisco, California

1 recruitingSan Francisco, California

Showing 1–1 of 1 trials

Recruiting
Phase 2

Tarlatamab in Advanced Delta-like 3 (DLL3)-Expressing Tumors Including Neuroendocrine Neoplasms

DLL3-expressing TumorsAdvanced Tumors
Jonsson Comprehensive Cancer Center29 enrolled5 locationsNCT06788938